PAVM experienced a dramatic collapse in net income from $39.8M to $401K while meaningfully reducing operating losses and substantially improving cash flow efficiency.
The severe decline in net income suggests the prior year likely included significant one-time gains or asset sales that did not recur, while the underlying operational improvements indicate management is successfully controlling cash burn. The substantial reduction in total liabilities from $37.7M to $16.5M alongside modest asset growth suggests meaningful debt restructuring or settlement activity that has strengthened the balance sheet foundation.
PAVM's financial profile shows a tale of two narratives - while net income collapsed from the prior year's elevated levels, the company demonstrated meaningful operational discipline with substantially improved operating cash flow and reduced R&D expenses. The balance sheet strengthened considerably through a major reduction in total liabilities while maintaining stable cash levels and growing total assets, suggesting successful debt management and capital structure optimization that positions the company on more sustainable footing despite the earnings volatility.
Net income declined 99% — review whether driven by operations, interest costs, or non-recurring items.
Operating cash flow surged 84.5% — exceptional cash generation, highest quality earnings signal.
Receivables declined — improved collection efficiency or conservative revenue recognition.
Current liabilities reduced — improved short-term financial position and working capital health.
Liabilities reduced 56.2% — deleveraging improves balance sheet strength and financial flexibility.
Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.
Capex reduced 43.6% — investment cycle winding down or capital discipline; may improve near-term free cash flow.
Cash grew 29.8% — improving liquidity position supports investment and shareholder returns.
Asset base grew 26.6% — expansion through organic growth, acquisitions, or capital deployment.
R&D spending cut 24.3% — could signal cost discipline or concerning reduction in innovation investment.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →